Childhood Asthma in Urban Settings Clinical Research Network
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Allergy and Infectious Diseases is preparing to fund the Childhood Asthma in Urban Settings Clinical Research Network to conduct multi-site clinical research focused on preventing and treating asthma in economically disadvantaged children living in urban areas with high disease burden. The network will develop and evaluate novel hypotheses and interventions aimed at asthma prevention, with particular emphasis on identifying and testing new treatment targets, including those relevant to type 2 low asthma phenotypes. It will also investigate the connections between upper and lower airway diseases and employ systems biology approaches to uncover distinct disease endotypes that can inform the development of targeted therapies. This initiative is authorized under Sections 301 and 405 of the Public Health Service Act and governed by Federal Regulations 42 CFR Part 52 and 2 CFR Part 200, ensuring compliance with federal grant standards. The opportunity is forecasted for release in June 2026, with all inquiries directed to the Division of Allergy, Immunology, and Transplantation CAUSE Program Group via the designated email address.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the continued support of the Childhood Asthma in Urban Settings Clinical Research Network (CAUSE) network. The CAUSE network will support multi-site clinical studies and trials on the prevention and treatment of asthma in economically disadvantaged pediatric populations where disease burden is high. The objectives of the CAUSE network are to develop and test innovative hypotheses and strategies for asthma prevention; identify/test new treatment targets (including targets for intervention based on mechanisms of type 2 low asthma); and continue to explore the risk relationship between upper and lower airway. Using systems biology approaches, CAUSE will continue to identify disease endotypes that may be suitable targets for existing and novel therapeutic modalities. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
